Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$54,128
-$14,306 QoQ
Shares Held
38,663
-4.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 145 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Derivatives in CHRS
reported options exposure · as of Mar 31, 2026CallValue
$21,970
CallShares
13,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. CHRS ranks #236 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in CHRS
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,128 | 38,663 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,970 | 13,000 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $68,434 | 40,494 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $856,982 | 603,510 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $36,778 | 25,900 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $44,936 | 27,400 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $344,365 | 209,980 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $46,281 | 63,313 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $30,699 | 22,246 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $456,366 | 330,700 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $70,309 | 67,606 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $360,657 | 208,473 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $864,131 | 361,562 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $1,844,473 | 553,896 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $892,505 | 238,638 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,082,191 | 487,633 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $731,475 | 106,941 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $104,629 | 13,211 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $228,784 | 23,807 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $635,737 | 87,809 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $559,003 | 43,300 | Put | Defined | 2022-05-17 | |
| 2022-03-31 | $676,328 | 52,388 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $265,031 | 16,606 | Shares | Defined | 2022-02-15 | |
| 2021-12-31 | $274,512 | 17,200 | Call | Defined | 2022-02-15 | |
| 2021-09-30 | $584,786 | 36,390 | Shares | Defined | 2021-11-16 | |
| 2021-09-30 | $419,427 | 26,100 | Put | Defined | 2021-11-16 | |
| 2021-09-30 | $204,089 | 12,700 | Call | Defined | 2021-11-16 | |
| 2021-06-30 | $383,091 | 27,700 | Put | Defined | 2021-08-16 | |
| 2021-06-30 | $638,461 | 46,165 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $302,877 | 21,900 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $260,058 | 17,800 | Put | Defined | 2021-05-18 | |
| 2021-03-31 | $356,775 | 24,420 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $863,437 | 49,680 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $849,838 | 46,338 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $219,678 | 12,300 | Call | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||